1.
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
by El-Serag, Hashem B
Gut, 2014, Vol.63 (6), p.871-880
2.
3.
Symptomatic reflux disease: the present, the past and the future
by Boeckxstaens, Guy
Gut, 2014, Vol.63 (7), p.1185-1193
4.
Obesity increases oesophageal acid exposure
by El-Serag, Hashem B
Gut, 2007, Vol.56 (6), p.749-755
5.
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study
by El-Serag, Hashem B
Gut, 2014, Vol.63 (2), p.220-229
6.
Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus
by Jiao, Li
Cancer causes & control, 2013, Vol.24 (5), p.1005-1014
7.
Reducing referral delays in colorectal cancer diagnosis: is it about how you ask?
by Singh, Hardeep
BMJ quality & safety, 2010, Vol.19 (5), p.e27-e27
8.
A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women
by Chen, Liang
Cancer epidemiology, 2016, Vol.42, p.115-123
9.
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA
by El-Serag, Hashem B
Gut, 2011, Vol.60 (7), p.992-997
10.
Republished: Symptomatic reflux disease: the present, the past and the future
by Boeckxstaens, Guy
Postgraduate Medical Journal, 2015, Vol.91 (1071), p.46-54
11.
Epidemiology of Non-Erosive Reflux Disease
by El-Serag, Hashem B
Digestion, 2008, Vol.78 (1), p.6-10
12.
Is There a Race‐Based Disparity in the Survival of Veterans with HIV?
by Giordano, Thomas P.
Journal of general internal medicine : JGIM, 2006, Vol.21 (6), p.613-617
13.
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress
by SAVAS, L. S.
Alimentary pharmacology & therapeutics, 2009, Vol.29 (1), p.115-125
14.
Irritable bowel syndrome symptoms and health related quality of life in female veterans
by GRAHAM, D. P.
Alimentary pharmacology & therapeutics, 2010, Vol.31 (2), p.261-273
15.
Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States
by Le, Anne
Annals of surgical oncology, 2007, Vol.14 (9), p.2519-2527
16.
Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer
by Walker, M.
Alimentary pharmacology & therapeutics, 2016, Vol.43 (5), p.621-630
17.
Metabolic syndrome and the risk of Barrett's oesophagus in white males
by Thrift, A. P.
Alimentary pharmacology & therapeutics, 2015, Vol.41 (11), p.1182-1189
18.
Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data
by Husain, N.
Alimentary pharmacology & therapeutics, 2014, Vol.40 (8), p.949-954
19.
Dietary consumption of meat, fat, animal products and advanced glycation end‐products and the risk of Barrett's oesophagus
by Jiao, L.
Alimentary pharmacology & therapeutics, 2013, Vol.38 (7), p.817-824
20.
The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy
by Sealock, R. J.
Alimentary pharmacology & therapeutics, 2013, Vol.37 (8), p.825-832
